Patent details

Basic Information

Publication number:

EP3299030

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP171993728

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PARENTERAL NOROVIRUS VACCINE FORMULATIONS

French Title of Invention:

FORMULATIONS DE VACCIN PARENTÉRAL CONTRE UN NOROVIRUS

German Title of Invention:

PARENTERALE NOROVIRUS-IMPFSTOFFFORMULIERUNGEN

SPC Number:

Dates

Filing date:

11/07/2012

Grant date:

08/06/2022

EP Publication Date:

28/03/2018

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/06/2022

EP B1 Publication Date:

08/06/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/07/2022

Expiration date:

11/07/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/06/2022

 

 

Name:

Takeda Vaccines, Inc.

Address:

75 Sidney Street, Cambridge, MA 02139, United States (US)

Inventor

1

Name:

MENDELMAN, Paul, M.

Address:

United States (US)

2

Name:

BARGATZE, Robert, F.

Address:

United States (US)

3

Name:

RICHARDSON, Charles

Address:

United States (US)

Priority

Priority Number:

201161506447 P

Priority Date:

11/07/2011

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/125;

Publication

European Patent Bulletin

1

Issue number:

202223

Publication date:

08/06/2022

Description:

Grant (B1)

2

Issue number:

202227

Publication date:

06/07/2022

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages